Recent progress in migraine pathophysiology: Role of cortical spreading depression and magnetic resonance imaging

European Journal of Neuroscience

Volumn 38, Issue 11, 2013, Pages 3540-3551

  Bhaskar, Sonu ^a,b   Saeidi, Kolsoum ^c   Borhani, Parvin ^c   Amiri, Houshang ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CSD; DTI; FMRI; Headache; Neuroimaging

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE RECEPTOR; GELATINASE B; NEUROTRANSMITTER;

BOLD SIGNAL; BRAIN STEM; DIFFUSION TENSOR IMAGING; DOPAMINERGIC TRANSMISSION; DRUG CONTRAINDICATION; ENDOPHENOTYPE; GENETICS; HEADACHE; HEREDITY; HUMAN; IMAGE ANALYSIS; MIGRAINE; MIGRAINE AURA; MIGRAINE WITHOUT AURA; MORBIDITY; NEOCORTEX; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPREADING CORTICAL DEPRESSION; STRUCTURE ANALYSIS; SYMPTOMATOLOGY; TREATMENT PLANNING; VOXEL BASED MORPHOMETRY;

CSD; DTI; FMRI; HEADACHE; NEUROIMAGING;

ANIMALS; CEREBRAL CORTEX; CORTICAL SPREADING DEPRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MIGRAINE DISORDERS;

EID: 84897051293     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12368     Document Type: Review

References (143)

1. Absinta, M., Rocca, M.A., Colombo, B., Copetti, M., De Feo, D., Falini, A., Comi, G. & Filippi, M. (2012) Patients with migraine do not have MRI-visible cortical lesions. J. Neurol., 259, 2695-2698.
2. Adami, A., Rossato, G., Cerini, R., Thijs, V.N., Pozzi-Mucelli, R., Anzola, G.P., Del Sette, M., Finocchi, C., Meneghetti, G., Zanferrari, C. & Group, S.A.M.S. (2008) Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology, 71, 101-107.
3. Afridi, S. & Goadsby, P.J. (2003) New onset migraine with a brain stem cavernous angioma. J. Neurol. Neurosur. Ps., 74, 680-682.
4. Afridi, S.K. & Goadsby, P.J. (2006) Neuroimaging of migraine. Curr. Pain Headache R., 10, 221-224.
5. Afridi, S.K., Giffin, N.J., Kaube, H., Friston, K.J., Ward, N.S., Frackowiak, R.S. & Goadsby, P.J. (2005a) A positron emission tomographic study in spontaneous migraine. Arch. Neurol., 62, 1270-1275.
6. Afridi, S.K., Matharu, M.S., Lee, L., Kaube, H., Friston, K.J., Frackowiak, R.S. & Goadsby, P.J. (2005b) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain, 128, 932-939.
7. Agarwal, S., Magu, S. & Kamal, K. (2008) Reversible white matter abnormalities in a patient with migraine. Neurol. India, 56, 182-185.
8. Aguggia, M. (2012) Allodynia and migraine. Neurol. Sci., 33(Suppl 1), S9-S11.
9. Akerman, S. & Goadsby, P.J. (2007) Dopamine and migraine: biology and clinical implications. Cephalalgia, 27, 1308-1314.
10. Anttila, V., Stefansson, H., Kallela, M., Todt, U., Terwindt, G.M., Calafato, M.S., Nyholt, D.R., Dimas, A.S., Freilinger, T., Muller-Myhsok, B., Artto, V., Inouye, M., Alakurtti, K., Kaunisto, M.A., Hamalainen, E., de Vries, B., Stam, A.H., Weller, C.M., Heinze, A., Heinze-Kuhn, K., Goebel, I., Borck, G., Gobel, H., Steinberg, S., Wolf, C., Bjornsson, A., Gudmundsson, G., Kirchmann, M., Hauge, A., Werge, T., Schoenen, J., Eriksson, J.G., Hagen, K., Stovner, L., Wichmann, H.E., Meitinger, T., Alexander, M., Moebus, S., Schreiber, S., Aulchenko, Y.S., Breteler, M.M., Uitterlinden, A.G., Hofman, A., van Duijn, C.M., Tikka-Kleemola, P., Vepsalainen, S., Lucae, S., Tozzi, F., Muglia, P., Barrett, J., Kaprio, J., Farkkila, M., Peltonen, L., Stefansson, K., Zwart, J.A., Ferrari, M.D., Olesen, J., Daly, M., Wessman, M., van den Maagdenberg, A.M., Dichgans, M., Kubisch, C., Dermitzakis, E.T., Frants, R.R., Palotie, A. & International Headache Genetics Consortium (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet., 42, 869-873.
11. Aradi, M., Schwarcz, A., Perlaki, G., Orsi, G., Kovacs, N., Trauninger, A., Kamson, D.O., Erdelyi-Botor, S., Nagy, F., Nagy, S.A., Doczi, T., Komoly, S. & Pfund, Z. (2013) Quantitative MRI studies of chronic brain white matter hyperintensities in migraine patients. Headache, 53, 752-763.
12. Ashburner, J. & Friston, K.J. (2000) Voxel-based morphometry - the methods. NeuroImage, 11, 805-821.
13. Ashkenazi, A., Sholtzow, M., Shaw, J.W., Burstein, R. & Young, W.B. (2007) Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia, 27, 111-117.
14. Bahra, A., Matharu, M.S., Buchel, C., Frackowiak, R.S. & Goadsby, P.J. (2001) Brainstem activation specific to migraine headache. Lancet, 357, 1016-1017.
15. Barbanti, P., Bronzetti, E., Ricci, A., Cerbo, R., Fabbrini, G., Buzzi, M.G., Amenta, F. & Lenzi, G.L. (1996) Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci. Lett., 207, 73-76.
16. Barbanti, P., Fabbrini, G. & Cerbo, R. (1998) Dopamine and migraine. Neurology, 51, 925.
17. Barbanti, P., Fabbrini, G., Ricci, A., Pascali, M.P., Bronzetti, E., Amenta, F., Lenzi, G.L. & Cerbo, R. (2000a) Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia, 20, 15-19.
18. Barbanti, P., Fabbrini, G., Vanacore, N., Rum, A., Lenzi, G.L., Meco, G. & Cerbo, R. (2000b) Dopamine and migraine: does Parkinson's disease modify migraine course? Cephalalgia, 20, 720-723.
19. Bes, A., Dupui, P., Guell, A., Bessoles, G. & Geraud, G. (1986) Pharmacological exploration of dopamine hypersensitivity in migraine patients. Int. J. Clin. Pharm. Res., 6, 189-192.
20. Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J.M., Grazu, V., Borm, P., Estrada, G., Ntziachristos, V. & Razansky, D. (2010) Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part. Fibre Toxicol., 7, 3.
21. Biondi, D.M. (2006) Is migraine a neuropathic pain syndrome? Curr. Pain Headache R., 10, 167-178.
22. Borsook, D., Burstein, R., Moulton, E. & Becerra, L. (2006) Functional imaging of the trigeminal system: applications to migraine pathophysiology. Headache, 46(Suppl 1), S32-S38.
23. Bramanti, P., Grugno, R., Vitetta, A., Di Bella, P., Muscara, N. & Nappi, G. (2005a) Migraine with and without aura: electrophysiological and functional neuroimaging evidence. Funct. Neurol., 20, 29-32.
24. Bramanti, P., Grugno, R., Vitetta, A., Marino, S., Di Bella, P. & Nappi, G. (2005b) Ictal and interictal hypoactivation of the occipital cortex in migraine with aura. A neuroimaging and electrophysiological study. Funct. Neurol., 20, 169-171.
25. Bugnicourt, J.M., Garcia, P.Y., Peltier, J., Bonnaire, B., Picard, C. & Godefroy, O. (2009) Incomplete posterior circle of willis: a risk factor for migraine? Headache, 49, 879-886.
26. Burstein, R., Yarnitsky, D., Goor-Aryeh, I., Ransil, B.J. & Bajwa, Z.H. (2000) An association between migraine and cutaneous allodynia. Ann. Neurol., 47, 614-624.
27. Burstein, R., Collins, B. & Jakubowski, M. (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol., 55, 19-26.
28. Bussone, G. (2004) Pathophysiology of migraine. Neurol. Sci., 25(Suppl 3), S239-S241.
29. Cao, Y., Welch, K.M., Aurora, S. & Vikingstad, E.M. (1999) Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch. Neurol., 56, 548-554.
30. Cao, Y., Aurora, S.K., Nagesh, V., Patel, S.C. & Welch, K.M. (2002) Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology, 59, 72-78.
31. Cerbo, R., Barbanti, P., Buzzi, M.G., Fabbrini, G., Brusa, L., Roberti, C., Zanette, E. & Lenzi, G.L. (1997) Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin. Neuropharmacol., 20, 36-41.
32. Chalaupka, F.D. (2008) Reversible imaging abnormalities consistent with CSD during migraine without aura attack. Headache, 48, 1229-1232.
33. Charbit, A.R., Akerman, S. & Goadsby, P.J. (2010) Dopamine: what's new in migraine? Curr. Opin. Neurol., 23, 275-281.
34. Charles, A. & Brennan, K.C. (2010) The neurobiology of migraine. Handb. Clin. Neurol., 97, 99-108.
35. Chasman, D.I., Schurks, M., Anttila, V., de Vries, B., Schminke, U., Launer, L.J., Terwindt, G.M., van den Maagdenberg, A.M., Fendrich, K., Volzke, H., Ernst, F., Griffiths, L.R., Buring, J.E., Kallela, M., Freilinger, T., Kubisch, C., Ridker, P.M., Palotie, A., Ferrari, M.D., Hoffmann, W., Zee, R.Y. & Kurth, T. (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet., 43, 695-698.
36. Chiapparini, L., Ferraro, S., Grazzi, L. & Bussone, G. (2010) Neuroimaging in chronic migraine. Neurol. Sci., 31(Suppl 1), S19-S22.
37. Colombo, B., Dalla Libera, D. & Comi, G. (2011) Brain white matter lesions in migraine: what's the meaning? Neurol. Sci., 32(Suppl 1), S37-S40.
38. Colombo, B., Dalla Costa, G., Dalla Libera, D. & Comi, G. (2012) From neuroimaging to clinical setting: what have we learned from migraine pain? Neurol. Sci., 33(Suppl 1), S95-S97.
39. Cooke, L., Eliasziw, M. & Becker, W.J. (2007) Cutaneous allodynia in transformed migraine patients. Headache, 47, 531-539.
40. Cooney, B.S., Grossman, R.I., Farber, R.E., Goin, J.E. & Galetta, S.L. (1996) Frequency of magnetic resonance imaging abnormalities in patients with migraine. Headache, 36, 616-621.
41. Cuadrado, M.L., Young, W.B., Fernandez-de-las-Penas, C., Arias, J.A. & Pareja, J.A. (2008) Migrainous corpalgia: body pain and allodynia associated with migraine attacks. Cephalalgia, 28, 87-91.
42. Cutrer, F.M. & Black, D.F. (2006) Imaging findings of migraine. Headache, 46, 1095-1107.
43. DaSilva, A.F., Granziera, C., Snyder, J. & Hadjikhani, N. (2007a) Thickening in the somatosensory cortex of patients with migraine. Neurology, 69, 1990-1995.
44. DaSilva, A.F., Granziera, C., Tuch, D.S., Snyder, J., Vincent, M. & Hadjikhani, N. (2007b) Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. NeuroReport, 18, 301-305.
45. Datta, R., Detre, J.A., Aguirre, G.K. & Cucchiara, B. (2011) Absence of changes in cortical thickness in patients with migraine. Cephalalgia, 31, 1452-1458.
46. Datta, R., Aguirre, G.K., Hu, S., Detre, J.A. & Cucchiara, B. (2013) Interictal cortical hyperresponsiveness in migraine is directly related to the presence of aura. Cephalalgia, 33, 365-374.
47. Del Sette, M., Dinia, L., Bonzano, L., Roccatagliata, L., Finocchi, C., Parodi, R.C., Sivori, G. & Gandolfo, C. (2008) White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia, 28, 376-382.
48. Dinia, L., Bonzano, L., Albano, B., Finocchi, C., Del Sette, M., Saitta, L., Castellan, L., Gandolfo, C. & Roccatagliata, L. (2013) White matter lesion progression in migraine with aura: a clinical and MRI longitudinal study. J. Neuroimaging, 23, 47-52.
49. Esserlind, A.L., Christensen, A.F., Le, H., Kirchmann, M., Hauge, A.W., Toyserkani, N.M., Hansen, T., Grarup, N., Werge, T., Steinberg, S., Bettella, F., Stefansson, H. & Olesen, J. (2013) Replication and meta-analysis of common variants identifies a genome-wide significant locus in migraine. Eur. J. Neurol., 20, 765-772.
50. Fanciullacci, M., Alessandri, M. & Del Rosso, A. (2000) Dopamine involvement in the migraine attack. Funct. Neurol., 15(Suppl 3), 171-181.
51. Fernandez-de-las-Penas, C., Madeleine, P., Cuadrado, M.L., Ge, H.Y., Arendt-Nielsen, L. & Pareja, J.A. (2009) Pressure pain sensitivity mapping of the temporalis muscle revealed bilateral pressure hyperalgesia in patients with strictly unilateral migraine. Cephalalgia, 29, 670-676.
52. Fernandez-de-las-Penas, C., Madeleine, P., Caminero, A.B., Cuadrado, M.L., Arendt-Nielsen, L. & Pareja, J.A. (2010) Generalized neck-shoulder hyperalgesia in chronic tension-type headache and unilateral migraine assessed by pressure pain sensitivity topographical maps of the trapezius muscle. Cephalalgia, 30, 77-86.
53. Filippi, M. & Rocca, M.A. (2008) Headache and migraine. Neurol. Sci., 29(Suppl 3), 336-338.
54. Fischl, B. & Dale, A.M. (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. USA, 97, 11050-11055.
55. Formisano, E., De Martino, F. & Valente, G. (2008) Multivariate analysis of fMRI time series: classification and regression of brain responses using machine learning. Magn. Reson. Imaging, 26, 921-934.
56. Freilinger, T., Anttila, V., de Vries, B., Malik, R., Kallela, M., Terwindt, G.M., Pozo-Rosich, P., Winsvold, B., Nyholt, D.R., van Oosterhout, W.P., Artto, V., Todt, U., Hamalainen, E., Fernandez-Morales, J., Louter, M.A., Kaunisto, M.A., Schoenen, J., Raitakari, O., Lehtimaki, T., Vila-Pueyo, M., Gobel, H., Wichmann, E., Sintas, C., Uitterlinden, A.G., Hofman, A., Rivadeneira, F., Heinze, A., Tronvik, E., van Duijn, C.M., Kaprio, J., Cormand, B., Wessman, M., Frants, R.R., Meitinger, T., Muller-Myhsok, B., Zwart, J.A., Farkkila, M., Macaya, A., Ferrari, M.D., Kubisch, C., Palotie, A., Dichgans, M., van den Maagdenberg, A.M. & International Headache Genetics Consortium (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet., 44, 777-782.
57. Galeotti, N., Ghelardini, C., Grazioli, I. & Uslenghi, C. (2002) Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine. Pharmacol. Res., 46, 245-250.
58. Garcia-Martin, E., Martinez, C., Serrador, M., Alonso-Navarro, H., Navacerrada, F., Agundez, J.A. & Jimenez-Jimenez, F.J. (2010) Dopamine receptor 3 (DRD3) polymorphism and risk for migraine. Eur. J. Neurol., 17, 1220-1223.
59. Glahn, D.C., Thompson, P.M. & Blangero, J. (2007) Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum. Brain Mapp., 28, 488-501.
60. Goadsby, P.J., Charbit, A.R., Andreou, A.P., Akerman, S. & Holland, P.R. (2009) Neurobiology of migraine. Neuroscience, 161, 327-341.
61. Gorji, A., Scheller, D., Straub, H., Tegtmeier, F., Kohling, R., Hohling, J.M., Tuxhorn, I., Ebner, A., Wolf, P., Werner Panneck, H., Oppel, F. & Speckmann, E.J. (2001) Spreading depression in human neocortical slices. Brain Res., 906, 74-83.
62. Gottesman, I.I. & Gould, T.D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiat., 160, 636-645.
63. Granziera, C., DaSilva, A.F., Snyder, J., Tuch, D.S. & Hadjikhani, N. (2006) Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med., 3, e402.
64. Gursoy-Ozdemir, Y., Qiu, J., Matsuoka, N., Bolay, H., Bermpohl, D., Jin, H., Wang, X., Rosenberg, G.A., Lo, E.H. & Moskowitz, M.A. (2004) Cortical spreading depression activates and upregulates MMP-9. J. Clin. Invest., 113, 1447-1455.
65. Hadjikhani, N., Sanchez Del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., Kwong, K.K., Cutrer, F.M., Rosen, B.R., Tootell, R.B., Sorensen, A.G. & Moskowitz, M.A. (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. USA, 98, 4687-4692.
66. Hamilton, J.P., Chen, G., Thomason, M.E., Schwartz, M.E. & Gotlib, I.H. (2011) Investigating neural primacy in major depressive disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol. Psychiatr., 16, 763-772.
67. Hinds, O.P., Rajendran, N., Polimeni, J.R., Augustinack, J.C., Wiggins, G., Wald, L.L., Diana Rosas, H., Potthast, A., Schwartz, E.L. & Fischl, B. (2008) Accurate prediction of V1 location from cortical folds in a surface coordinate system. NeuroImage, 39, 1585-1599.
68. Huang, J., Cooper, T.G., Satana, B., Kaufman, D.I. & Cao, Y. (2003) Visual distortion provoked by a stimulus in migraine associated with hyperneuronal activity. Headache, 43, 664-671.
69. Huang, T.H., Hsu, W.C., Yeh, J.H., Chiu, H.C. & Chen, W.H. (2005) A case of ophthalmoplegic migraine mimicking ocular myasthenia gravis. Eur. Neurol., 53, 215-217.
70. Huang, J., DeLano, M. & Cao, Y. (2006) Visual cortical inhibitory function in migraine is not generally impaired: evidence from a combined psychophysical test with an fMRI study. Cephalalgia, 26, 554-560.
71. James, M.F., Smith, J.M., Boniface, S.J., Huang, C.L. & Leslie, R.A. (2001) Cortical spreading depression and migraine: new insights from imaging? Trends Neurosci., 24, 266-271.
72. Kim, J.H., Suh, S.I., Seol, H.Y., Oh, K., Seo, W.K., Yu, S.W., Park, K.W. & Koh, S.B. (2008) Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia, 28, 598-604.
73. Kruit, M.C., van Buchem, M.A., Hofman, P.A., Bakkers, J.T., Terwindt, G.M., Ferrari, M.D. & Launer, L.J. (2004) Migraine as a risk factor for subclinical brain lesions. JAMA, 291, 427-434.
74. Kruit, M.C., Launer, L.J., Overbosch, J., van Buchem, M.A. & Ferrari, M.D. (2009) Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia, 29, 351-359.
75. Kruit, M.C., van Buchem, M.A., Launer, L.J., Terwindt, G.M. & Ferrari, M.D. (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia, 30, 129-136.
76. Lashley, K.S. (1941) Patterns of cerebral integration by the scotomas of migraine. Arch. Neurol. Psy., 46, 331-339.
77. Lauritzen, M. (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain, 117(Pt 1), 199-210.
78. Lea, R.A., Dohy, A., Jordan, K., Quinlan, S., Brimage, P.J. & Griffiths, L.R. (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics, 3, 35-40.
79. Leao, A.A. (1947) Further observations on the spreading depression of activity in the cerebral cortex. J. Neurophysiol., 10, 409-414.
80. Linghorne, W.J. (1967) Headache and other head pain arising from the masticatory system. J. Can. Dent. Assoc. (Tor), 33, 69-74.
81. Lovati, C., D'Amico, D. & Bertora, P. (2009) Allodynia in migraine: frequent random association or unavoidable consequence?. Expert Rev. Neurother., 9, 395-408.
82. Maggioni, F., Viaro, F., Manara, R., Citton, V. & Zanchin, G. (2012) Reversible paresis of the left hand related to a migraine without aura attack. Neurologist, 18, 316-320.
83. Marmura, M.J. (2012) Use of dopamine antagonists in treatment of migraine. Curr. Treat. Option. N., 14, 27-35.
84. Martinez, H.R., Londono, O., Cantu-Martinez, L., del Carmen Tarin, L. & Castillo, C.D. (2003) Topiramate as an adjunctive treatment in migraine prophylaxis. Headache, 43, 1080-1084.
85. Mascia, A., Afra, J. & Schoenen, J. (1998) Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia, 18, 174-182.
86. Matharu, M.S., Good, C.D., May, A., Bahra, A. & Goadsby, P.J. (2003) No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur. J. Neurol., 10, 53-57.
87. Maude, S., Curtin, J., Breen, G., Collier, D., Russell, G., Shaw, D. & Clair, D.S. (2001) The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease. Psychiatr. Genet., 11, 49-52.
88. May, A. (2009) Morphing voxels: the hype around structural imaging of headache patients. Brain, 132, 1419-1425.
89. Moschiano, F., D'Amico, D., Schieroni, F. & Bussone, G. (2003) Neurobiology of chronic migraine. Neurol. Sci., 24(Suppl 2), S94-S96.
90. Moulton, E.A., Burstein, R., Tully, S., Hargreaves, R., Becerra, L. & Borsook, D. (2008) Interictal dysfunction of a brainstem descending modulatory center in migraine patients. PLoS ONE, 3, e3799.
91. Moulton, E.A., Becerra, L., Maleki, N., Pendse, G., Tully, S., Hargreaves, R., Burstein, R. & Borsook, D. (2011) Painful heat reveals hyperexcitability of the temporal pole in interictal and ictal migraine states. Cereb. Cortex, 21, 435-448.
92. Muller, K., Lohmann, G., Bosch, V. & von Cramon, D.Y. (2001) On multivariate spectral analysis of fMRI time series. NeuroImage, 14, 347-356.
93. Norman, K.A., Polyn, S.M., Detre, G.J. & Haxby, J.V. (2006) Beyond mind-reading: multi-voxel pattern analysis of fMRI data. Trends Cogn. Sci., 10, 424-430.
94. Olsen, T.S. (1995) Pathophysiology of the migraine aura: the spreading depression theory. Brain, 118(Pt 1), 307-308.
95. Palm-Meinders, I.H., Koppen, H., Terwindt, G.M., Launer, L.J., Konishi, J., Moonen, J.M., Bakkers, J.T., Hofman, P.A., van Lew, B., Middelkoop, H.A., van Buchem, M.A., Ferrari, M.D. & Kruit, M.C. (2012) Structural brain changes in migraine. JAMA, 308, 1889-1897.
96. Pan, H., Epstein, J., Silbersweig, D.A. & Stern, E. (2011) New and emerging imaging techniques for mapping brain circuitry. Brain Res. Rev., 67, 226-251.
97. Parsons, A.A. (2004) Cortical spreading depression: its role in migraine pathogenesis and possible therapeutic intervention strategies. Curr. Pain Headache R., 8, 410-416.
98. Peroutka, S.J. (1997) Dopamine and migraine. Neurology, 49, 650-656.
99. Peroutka, S.J., Wilhoit, T. & Jones, K. (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology, 49, 201-206.
100. Pietrobon, D. & Striessnig, J. (2003) Neurobiology of migraine. Nat. Rev. Neurosci., 4, 386-398.
101. Rao, R., Rosati, A., Liberini, P., Gipponi, S., Venturelli, E., Sapia, E., Ambrosi, C. & Padovani, A. (2008) Cerebrovascular risk factors and MRI abnormalities in migraine. Neurol. Sci., 29(Suppl 1), S144-S145.
102. Rebaudengo, N., Rainero, I., Parziale, A., Rosina, F., Pavanelli, E., Rubino, E., Mazza, C., Ostacoli, L. & Furlan, P.M. (2004) Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia, 24, 503-507.
103. Reddy, D.S. (2013) The pathophysiological and pharmacological basis of current drug treatment of migraine headache. Expert Rev. Clin. Pharmacol., 6, 271-288.
104. Rigatelli, G. (2008) Migraine and patent foramen ovale: connecting flight or one-way ticket? Expert Rev. Neurother., 8, 1331-1337.
105. Rocca, M.A., Colombo, B., Inglese, M., Codella, M., Comi, G. & Filippi, M. (2003a) A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine. J. Neurol. Neurosur. Ps., 74, 501-503.
106. Rocca, M.A., Colombo, B., Pagani, E., Falini, A., Codella, M., Scotti, G., Comi, G. & Filippi, M. (2003b) Evidence for cortical functional changes in patients with migraine and white matter abnormalities on conventional and diffusion tensor magnetic resonance imaging. Stroke, 34, 665-670.
107. Rocca, M.A., Ceccarelli, A., Falini, A., Colombo, B., Tortorella, P., Bernasconi, L., Comi, G., Scotti, G. & Filippi, M. (2006a) Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke, 37, 1765-1770.
108. Rocca, M.A., Ceccarelli, A., Falini, A., Tortorella, P., Colombo, B., Pagani, E., Comi, G., Scotti, G. & Filippi, M. (2006b) Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine. J. Neurol. Neurosur. Ps., 77, 686-689.
109. Rocca, M.A., Pagani, E., Colombo, B., Tortorella, P., Falini, A., Comi, G. & Filippi, M. (2008) Selective diffusion changes of the visual pathways in patients with migraine: a 3-T tractography study. Cephalalgia, 28, 1061-1068.
110. Rotstein, D.L., Aviv, R.I. & Murray, B.J. (2012) Migraine with aura associated with unilateral cortical increase in vascular permeability. Cephalalgia, 32, 1216-1219.
111. Russo, A., Tessitore, A., Esposito, F., Marcuccio, L., Giordano, A., Conforti, R., Truini, A., Paccone, A., d'Onofrio, F. & Tedeschi, G. (2012) Pain processing in patients with migraine: an event-related fMRI study during trigeminal nociceptive stimulation. J. Neurol., 259, 1903-1912.
112. Schick, S., Gahleitner, A., Wober-Bingol, C., Wober, C., Ba-Ssalamah, A., Schoder, M., Schindler, E. & Prayer, D. (1999) Virchow-Robin spaces in childhood migraine. Neuroradiology, 41, 283-287.
113. Schmitz, N., Admiraal-Behloul, F., Arkink, E.B., Kruit, M.C., Schoonman, G.G., Ferrari, M.D. & van Buchem, M.A. (2008a) Attack frequency and disease duration as indicators for brain damage in migraine. Headache, 48, 1044-1055.
114. Schmitz, N., Arkink, E.B., Mulder, M., Rubia, K., Admiraal-Behloul, F., Schoonman, G.G., Kruit, M.C., Ferrari, M.D. & van Buchem, M.A. (2008b) Frontal lobe structure and executive function in migraine patients. Neurosci. Lett., 440, 92-96.
115. Schwedt, T.J. & Dodick, D.W. (2009) Advanced neuroimaging of migraine. Lancet Neurol., 8, 560-568.
116. Seneviratne, U., Chong, W. & Billimoria, P.H. (2013) Brain white matter hyperintensities in migraine: clinical and radiological correlates. Clin. Neurol. Neurosur., 115, 1040-1043.
117. Shibata, K., Yamane, K. & Iwata, M. (2006) Change of excitability in brainstem and cortical visual processing in migraine exhibiting allodynia. Headache, 46, 1535-1544.
118. Shukla, R., Khanna, V.K., Vinod, P., Sankhwar, M.L. & Yadav, R.S. (2009) Platelet dopamine: D2 receptor binding in patients with migraine. Cephalalgia, 29, 532-538.
119. Silberstein, S.D. (2007) Migraine. In Schapira, A.H.V. (Ed.), Neurology and Clinical Neuroscience. Mosby, Philadelphia, PA, pp. 739-755.
120. Smith, M., Cros, D. & Sheen, V. (2002) Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology, 58, 1308-1310.
121. Stankewitz, A. & May, A. (2011) Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology, 77, 476-482.
122. Stovner, L.J. & Andree, C. (2010) Prevalence of headache in Europe: a review for the Eurolight project. J. Headache Pain, 11, 289-299.
123. Takano, T. & Nedergaard, M. (2009) Deciphering migraine. J. Clin. Invest., 119, 16-19.
124. Tessitore, A., Russo, A., Esposito, F., Giordano, A., Taglialatela, G., De Micco, R., Cirillo, M., Conte, F., d'Onofrio, F., Cirillo, S. & Tedeschi, G. (2011) Interictal cortical reorganization in episodic migraine without aura: an event-related fMRI study during parametric trigeminal nociceptive stimulation. Neurol. Sci., 32(Suppl 1), S165-S167.
125. Teutsch, S., Herken, W., Bingel, U., Schoell, E. & May, A. (2008) Changes in brain gray matter due to repetitive painful stimulation. NeuroImage, 42, 845-849.
126. Thacker, N.A., Williamson, D.C. & Pokric, M. (2004) Voxel based analysis of tissue volume from MRI data. Brit. J. Radiol., 77(Spec No 2), S114-S125.
127. Todt, U., Netzer, C., Toliat, M., Heinze, A., Goebel, I., Nurnberg, P., Gobel, H., Freudenberg, J. & Kubisch, C. (2009) New genetic evidence for involvement of the dopamine system in migraine with aura. Hum. Genet., 125, 265-279.
128. de Tommaso, M., Losito, L., Libro, G., Guido, M., Di Fruscolo, O., Sardaro, M., Sciruicchio, V., Lamberti, P. & Livrea, P. (2005) Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack. Cephalalgia, 25, 359-368.
129. Tortorella, P., Rocca, M.A., Colombo, B., Annovazzi, P., Comi, G. & Filippi, M. (2006) Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J. Neurol. Sci., 244, 137-141.
130. Trauninger, A., Leel-Ossy, E., Kamson, D.O., Poto, L., Aradi, M., Kover, F., Imre, M., Komaromy, H., Erdelyi-Botor, S., Patzko, A. & Pfund, Z. (2011) Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J. Headache Pain, 12, 97-103.
131. Valfre, W., Rainero, I., Bergui, M. & Pinessi, L. (2008) Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache, 48, 109-117.
132. Vecchia, D. & Pietrobon, D. (2012) Migraine: a disorder of brain excitatory-inhibitory balance? Trends Neurosci., 35, 507-520.
133. Verhoeff, N.P., Visser, W.H., Ferrari, M.D., Saxena, P.R. & van Royen, E.A. (1993) Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier? Cephalalgia, 13, 325-329.
134. Vollbracht, S. & Rapoport, A.M. (2013) The pipeline in headache therapy. CNS Drugs, 27, 717-729.
135. Vos, T., et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163-2196.
136. Waelkens, J. (1984) Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia, 4, 85-90.
137. Weiller, C., May, A., Limmroth, V., Juptner, M., Kaube, H., Schayck, R.V., Coenen, H.H. & Diener, H.C. (1995) Brain stem activation in spontaneous human migraine attacks. Nat. Med., 1, 658-660.
138. Welch, K.M., Cao, Y., Aurora, S., Wiggins, G. & Vikingstad, E.M. (1998) MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology, 51, 1465-1469.
139. Welch, K.M., Nagesh, V., Aurora, S.K. & Gelman, N. (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache, 41, 629-637.
140. Wolff, H.G. (1948) Headache and Other Head Pain. Oxford University Press, New York.
141. Wolff, H.G. (1963) Headache and Other Head Pain. Oxford University Press, New York.
142. Yilmaz-Kusbeci, O., Gocmen-Mas, N., Yucel, A., Karabekir, H.S., Ertekin, T. & Yazici, A.C. (2010) Evaluation of cerebellar and cerebral volume in migraine with aura: a stereological study. Cerebellum, 9, 345-351.
143. Young, W.B. (2009) Allodynia as a complication of migraine: background and management. Curr. Treat. Option. N., 11, 3-9.